Clinical Neuroradiology

Frederik Barkhof received his M.D. from VU University, Amsterdam (NL), in 1988, and defended his Ph.D. thesis in 1992, for which he received the Philips Prize for Radiology (1992) and the Lucien Appel Prize for Neuroradiology (1994). Since 2001, he serves as a Full Professor in Neuroradiology in the Department of Radiology and Nuclear Medicine at VUmc. In 2015, he was appointed Full Professor of Neuroradiology at the institutes of Biomedical Engineering and Neurology at UCL in London (UK) to translate novel imaging techniques and became a fellow of the Royal College of Radiology. Professor Barkhof was the Chairman of the Dutch Society of Neuroradiology and the MAGNIMS study group for many years. He leads the Queen Square MS Centre Trial Unit, involved in the analysis of multicenter drug trials. He serves on the editorial boards of Radiology, Brain, Multiple Sclerosis Journal, Neuroradiology, and Neurology. In 2018 he received the John Dystel Prize by the AAN and NMSS for his significant contributions to MS research. In 2019, he became a senior fellow of the ISMRM. Barkhof's research interests focus on childhood white matter disease, multiple sclerosis (spinal cord MRI, gray matter, atrophy, and histopathology correlations), aging (white matter lesions and microbleeds), and dementia (structural, functional, and molecular MR and PET). He has (co)authored more than 1000 papers referenced in PubMed, and is listed among the 3000 most influential scientists worldwide by Thompson-Reuters. He is the author of the books Neuroimaging in Dementia and Clinical Applications of Functional Brain MRI. Cumulatively, he has received in excess of ?25 million in grant money from various national and international funding agencies and has performed contract research for all major pharmaceutical companies, with a cumulative contract value exceeding ?15 million. More than 40 Ph.D. students have graduated under his supervision and 3 of them have subsequently attained a full professorship. ¿ Hans Rolf Jäger studied Medicine at the Universities of Freiburg, Germany, and Montpellier, France (as recipient of a bursary from the French government). He obtained his M.D. with "magna cum laude" at the University of Freiburg in 1983. After 3 years in Internal Medicine, he underwent training in Radiology at the Hammersmith Hospital, London, and obtained the Fellowship of the Royal College of Radiologists in 1991. Subsequently, he trained in Neuroradiology at the National Hospital for Neurology and Neurosurgery, Queen Square, London, and in Interventional Neuroradiology with Pierre Lasjaunias at Hôpital Bicêtre, Paris. Rolf Jäger became Consultant Neuroradiologist at the National Hospital for Neurology and Neurosurgery in 1997, with joint academic appointments at the UCL Institute of Neurology, where he was promoted to Full Professor in Neuroradiology in 2014. During the course of his career, Rolf Jäger has been implementing advanced MRimaging techniques, such as gadolinium-based perfusion techniques, hemorrhage-sensitive imaging (T2_ and SWI), carotid plaque imaging, intracranial vessel wall imaging, and ASL perfusion imaging and angiography. He thereby created platforms for clinical translational research, the results of which made seminal contributions to the understanding of disease processes and influenced patient management. His clinical interest and research focus are cerebrovascular diseases, brain tumors, as well as neuro-infection (in particular HIV), and neurodegenerative diseases. He has been the imaging lead of several national and international multicenter clinical trials in these fields with an overall grant funding of £5.6 million. Rolf Jäger has built strong research collaborations with leading academic institutions in Europe, the USA, and South America, and regularly supervises visiting fellows from these institutions. He has supervised 16 Ph.D. students at the UCL Institute of Neurology. He has published 180 peer-reviewed articles, in...